AI assistant
AMICUS THERAPEUTICS, INC. — Director's Dealing 2015
Mar 24, 2015
31523_dirs_2015-03-24_4c51f15d-63f5-412f-b0a6-774520670b09.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2015-03-20
Reporting Person: Dilone Enrique (VP, Technical Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-03-20 | Common stock | M | 14045 | $11.5108 | Acquired | 64045 | Direct |
| 2015-03-20 | Common srock | S | 14045 | $11.5108 | Disposed | 50000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-03-20 | Stock Options (right to buy) | $4.16 | M | 3250 | Disposed | 2019-11-16 | Common Stock (3250) | Direct |
| 2015-03-20 | Stock Options (right to buy) | $4.38 | M | 1896 | Disposed | 2022-06-04 | Common stock (1896) | Direct |
| 2015-03-20 | Stock Options (right to buy) | $3.53 | M | 2624 | Disposed | 2023-01-28 | Common stock (2624) | Direct |
| 2015-03-20 | Stock Options (right to buy) | $2.52 | M | 3463 | Disposed | 2023-06-18 | Common stock (3463) | Direct |
| 2015-03-20 | Stock Options (right to buy) | $2.45 | M | 2812 | Disposed | 2024-01-03 | Common stock (2812) | Direct |
Footnotes
F1: The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.
F2: This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.17 to $11.90. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F3: This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.17 to $11.90. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.